Trial intelligence / Profile preview

Low-dose pipamperone vs placebo for cognitive dysfunction in elderly inpatients

2006-005313-35Phase 4Active

Sponsor
GGZ Drenthe
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in confusion comparing Low-dose pipamperone with Placebo (2 arms). Primary endpoint: Clinical effect on cognitive functions. Started Jun 2008; status: active.

02

Drugs

pipamperone
03

Conditions

confusion

Beyond the preview

Go deeper on 2006-005313-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005313-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call